Reimagining Medicine slide image

Reimagining Medicine

Company overview Financial review Conclusions Appendix References Harry Kirsch Chief Financial Officer Financial review and 2023 guidance 18 Investor Relations | Q2 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation